Microglia are resident monocyte-lineaged cells in the brain . Their characteristic feature is that they react to injury and diseases of the brain and become morphologically and functionally activated. Although some triggar molecules which activate microglia are predicted to be released from injured or affected cells, such molecules have not yet been identified. The main role of activated microglia is believed to be in brain defense , as scavengers of dead cells, and as immune or immunoeffector cells . Recent biochemical and neurobiological studies have further indicated that they significantly affect the pathological state and/or regulate the regenerative state and remodeling of the brain by producing a variety of biologically active molecules including cytotoxic and neuro trophic molecules.
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Among glial cell types of the central nervous system (CNS), microglia were found to be the third glial cell type by del Rio Hortega (1) . This cell type is observed uniformly in a scattered fashion throughout the normal adult brain, com prising approximately 5-20% of all glial cells (2) . As the brain develops, ameboid microglia decrease in number and appear to be replaced by increasing numbers of ramified microglia, which have small cells bodies with long, branched processes ( Fig. 1) . Although ameboid micro glia are generally believed to transform into ramified mi croglia during brain development, the exact relationship between these two types of microglia is still unclear. Rami fied microglia are thought of as being functionally inactive or in a resting state and are called "resting microglia." As long as the brain is maintained in healthy condition, the microglial cell density and ramified-morphology is sus tained.
When the brain is injured or affected by brain diseases, ramified microglia morphologically transform into "acti vated microglia" or "reactive microglia," which show re tracted processes and enlarged cell bodies and become pro liferative at the affected site (Fig. 1) . These transformed microglia are functionally activated and appear to be impli cated in many pathological states. In particular, their cyto- Biochemical Society toxic and inflammatory roles have been determined. The origin of resident microglia is generally considered to be bone marrow-derived monocytes (3) (4) (5) . At early embry onic stages, monocytes enter the brain parenchyma through the blood brain barrier (BBB), and thereafter set tle, transform, and mature into ramified microglia, either through or not through the stage of ameboid microglia (Fig.  1) . Actually, microglia are characterized by monocyte/mac rophage antigens (described below). In contrast to this monocyte-origin theory, a neuroectodermal-origin theory has also been proposed. According to this theory, microglia are believed to be born in neuroectodermal-derived glio blasts (matrix cells) (6, 7) . Thus, the origin of resident microglia is still controversial, although the former theory is predominant Microglia have been generally believed to act primarily as a defence line of the brain. If the CNS is infected, rami fied microglia transform into phagocytes (activated micro glia) and phagocytose the infectious microbes. Dead or dying cells in the CNS are also engulfed by ramified micro glia-derived macrophages. An immune or immunoeffector role of microglia in the brain has been proposed due to their immunological properties (5) . Activated microglia can function as antigen-presenting cells in the immune system when the BBB is disrupted.
In addition, microglia have been shown to have the ability to produce a variety of bio logically-active substances which induce inflammation and cell death, and regulate the regenerative processes. Micro glia currently are accepted as "a sensor for pathological events" in the brain (8 In acute injury such as axotomy of the facial nerve, microglia in the facial nucleus begin to change morphologi cally just after transection and proliferate 2-3 days later ( Fig. 2A) . Subsequently, the activated microglia increase in number over a period of 1-2 weeks and surround injured motoneuron cell bodies ( Fig. 2A) . After the persistent acti vation, they gradually regenerate and return to the mor phology and cell density of the ramified type. The state of activated microglia in the axotomized facial nucleus is divided into two, based on phagocytic properties (5, 9) ( Fig.  2A) . One state is activated (OX42+, Iba1+) but non-phago cytic (ED1-). The other is activated (OX42+, Iba1+) and phagocytic (ED1-). Whether or not they express antigen for ED1 antibody depends on the presence or absence of dying cells in the milieu. These activated microglia are derived from resident ramified microglia, because facial nerve tran section at the stylomastoid foramaen does not injure the BBB of the axotomized facial nucleus and no peripheral monocyte-lineage cells infiltrate into the brain paren chyma. The molecular and cellular mechanisms involved in microglial activation have been analyzed (10, 11) . General interest has been shown in what molecule(s) activate microglia in vivo. To date, various kinds of stimulators for microglial activation have been predicted (Fig. 3) . One cate gory is non-material stimulators. The electrical change re sulting from neuronal injury and changes in the ion milieu around injured neurons are candidates. The other category is that of biologically active substances, which may include low molecular weight molecules such as peptides and hor mones. Growth factors or cytokines may also be able to activate microglia. Among the cytokines are colony-stimu lating factors (CSFs) including macrophage (M)-CSF and granulocyte-macrophage (GM)-CSF (12) . Activated micro glia in the axotomized facial nucleus actually express a spe cific receptor for M-CSF and GM-CSF with which microglia can proliferate and transform. These CSFs are believed to be produced in the surrounding astrocytes (Fig. 3) . The requirement of the proliferating factor for microglia was verified in an axotomy model using osteopetrotic mouse (op/op mouse). The op/op mouse cannot produce active M-CSF due to a frame-shift mutation. The transec tion of the facial nerve in an op/op mouse results in fewer activated inicroglia in the axotomized facial nucleus (18), implying that M-CSF is a major factor for the activation and proliferation of microglia.
CSF-like proliferating factors for microglia were isolated from the neonatal rat brain as microglial mitogens (MMs) (19). MM1, whose molecular weight is 50kDa and pus 6.8, showed GM-CSF-like activity. On the other hand, MM2, with a molecular weight of 22kDa and a pI of 5.2, showed non-IL-3-like activity and was proved to be secreted by cul tured astrocytes. Both factors stimulate proliferation of ameboid microglia, but not of macroglia, monocytes, or peri toneal macrophages. They are produced in the injured brain, but not in the normal adult brain. As a whole, CSF or CSF-like factors may be responsible for the proliferation and activation of microglia in vivo.
Cytotoxicity of activated microglia
In chronic diseases, inflammatory reactions are long-last ing and accompanied by activation of microglia and infil trated blood derived cells, by which cytotoxic molecules and proinflammatory cytokines are suspected to be produced. Furthermore, these molecules cause harmful secondary reactions that may lead to the injury or death of weak neu rons. Although these complex events make it difficult to distinguish the functions of each cell type, activated micro glia have been generally suspected to be harmful. (Fig. 3) . However, the re lease of harmful factors from activated microglia and the cytotoxicity of these factors have been reported mainly based on in vitro studies. These findings regarding toxicity remain to he confirmed in vivo. Significance of activated microglia Activated microglia act primarily in the defence of the brain, as brain scavengers, and in tissue remodeling. An immune and/or immunoeffector role has also been proposed. Activated microglia have been suggested to be impli cated in pathogenesis and inflammation. They have also been shown to produce a variety of biological factors. Re cent biochemical and neurobiological studies have revealed that activated microglia produce and secrete not only cyto toxic/harmful molecules but also neurotrophic molecules including neurotrophins and neurotrophic cytokines.
As a whole, activated microglia appear to play a signifi cant role in pathological and regenerative states of the brain, expressing both or either of two potentially opposing functions: cytotoxic and neurotrophic actions.
